Abbott Laboratories (Pakistan) Limited (PSX:ABOT)

PSX:ABOT Balance Sheet

Financials in millions PKR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	9,436	13,338	6,182	5,037	7,966	819.35
Short-Term Investments	-	-	-	-	825.8	7,800
Cash & Short-Term Investments	9,436	13,338	6,182	5,037	8,792	8,619
Cash Growth	31.52%	115.74%	22.75%	-42.71%	2.00%	15.10%
Accounts Receivable	2,985	2,979	3,135	1,650	1,358	1,295
Other Receivables	1,382	846.75	1,498	2,430	1,329	741.78
Receivables	4,576	3,890	4,686	4,123	2,720	2,070
Inventory	16,957	13,118	11,224	13,290	8,856	7,006
Prepaid Expenses	-	103.21	93.42	156.09	262.2	70.31
Other Current Assets	1,849	544.78	1,076	593.62	1,199	666.78
Total Current Assets	32,818	30,993	23,262	23,199	21,829	18,432
Property, Plant & Equipment	15,745	15,636	14,253	13,375	11,989	10,006
Other Intangible Assets	0.73	0.83	1.25	12.68	26.9	49.02
Other Long-Term Assets	46.59	47.41	23.69	13.49	11.74	12.1
Total Assets	48,758	46,816	37,651	36,693	33,920	28,568

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1,607	1,885	2,054	2,015	2,045	1,328
Accrued Expenses	6,896	7,306	6,172	4,936	4,212	4,587
Short-Term Debt	-	-	-	-	-	15.78
Current Portion of Leases	99.92	158.3	22.68	105.99	120.21	93.74
Current Income Taxes Payable	-	246.96	-	-	-	-
Current Unearned Revenue	436.01	362.3	394.39	610.97	565.96	460.42
Other Current Liabilities	5,999	3,418	3,017	9,167	7,664	2,858
Total Current Liabilities	15,037	13,376	11,660	16,835	14,607	9,343
Long-Term Leases	349.55	329.68	29.55	52.23	127.08	133.94
Pension & Post-Retirement Benefits	460.41	494.94	1,184	1,049	1,580	1,466
Long-Term Deferred Tax Liabilities	813.98	989.97	1,053	519.57	499.66	269.74
Total Liabilities	16,661	15,191	13,927	18,456	16,814	11,213

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	979	979	979	979	979	979
Retained Earnings	28,797	28,573	20,995	15,821	15,068	15,483
Comprehensive Income & Other	2,321	2,074	1,750	1,437	1,059	892.15
Shareholders' Equity	32,097	31,625	23,725	18,237	17,106	17,355
Total Liabilities & Equity	48,758	46,816	37,651	36,693	33,920	28,568

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	449.47	487.98	52.23	158.22	247.29	243.46
Net Cash (Debt)	8,987	12,850	6,130	4,878	8,545	8,376
Net Cash Growth	33.85%	109.61%	25.66%	-42.91%	2.01%	25.53%
Net Cash Per Share	91.79	131.25	62.62	49.83	87.28	85.56
Filing Date Shares Outstanding	97.9	97.9	97.9	97.9	97.9	97.9
Total Common Shares Outstanding	97.9	97.9	97.9	97.9	97.9	97.9
Working Capital	17,781	17,617	11,601	6,364	7,222	9,089
Book Value Per Share	327.85	323.04	242.33	186.28	174.73	177.27
Tangible Book Value	32,096	31,625	23,723	18,225	17,079	17,306
Tangible Book Value Per Share	327.84	323.03	242.32	186.16	174.45	176.77
Land	-	23.4	23.4	23.4	23.4	23.4
Buildings	-	1,012	1,012	1,055	786.79	582.35
Machinery	-	23,454	20,385	18,096	17,018	14,207
Construction In Progress	-	2,313	2,859	2,804	1,860	1,726

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 17, 2026

Data Sources Report a data error